Ruilian Yu

Correlation of bevacizumab relative dose intensity with first-line treatment outcomes in advanced epithelial ovarian cancer

Objective: To evaluate the association between bevacizumab relative dose intensity (RDI) and first-line treatment outcomes in advanced epithelial ovarian cancer.Methods: We retrospectively analyzed 72 patients treated with first-line bevacizumab plus paclitaxel-platinum chemother...